HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Medori Selected Research

Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)

9/200512-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.
9/2005Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Medori Research Topics

Disease

5Schizophrenia (Dementia Praecox)
05/2008 - 09/2005
4Psychotic Disorders (Schizoaffective Disorder)
01/2008 - 09/2005
2Movement Disorders (Movement Disorder)
09/2005 - 09/2005
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2005 - 09/2005
1Relapsing-Remitting Multiple Sclerosis
08/2012
1Weight Gain
09/2005

Drug/Important Bio-Agent (IBA)

6Risperidone (Risperdal Consta)FDA LinkGeneric
05/2008 - 09/2005
2Antipsychotic Agents (Antipsychotics)IBA
11/2007 - 09/2005
2Methylphenidate (Ritalin)FDA LinkGeneric
09/2005 - 09/2005
1Biomarkers (Surrogate Marker)IBA
08/2012
1Olanzapine (Zyprexa)FDA Link
09/2005
1Pharmaceutical PreparationsIBA
09/2005

Therapy/Procedure

6Injections
05/2008 - 09/2005
1Therapeutics
08/2012
1Microspheres (Microsphere)
01/2008